Whole blood-based measurement of SARS-CoV-2-specific T cell responses reveals asymptomatic infection and vaccine efficacy in healthy subjects and patients with solid organ cancers

MLA

Thomas Tozer, et al. Whole Blood-Based Measurement of SARS-CoV-2-Specific T Cell Responses Reveals Asymptomatic Infection and Vaccine Efficacy in Healthy Subjects and Patients with Solid Organ Cancers. June 2021. EBSCOhost, https://doi.org/10.1101/2021.06.02.21258218.

APA

Thomas Tozer, Kate Davies, Lucy C. Fairclough, Martin J. Scurr, Michelle Somerville, Kerry Roberts, Andrew James Godkin, Mererid Evans, George Lippiatt, Andrew D. Westwell, Tara Rees, Mark R. Wills, Helen Lawton, Stephanie E A Burnell, Awen Gallimore, Amanda Jackson, Wioleta M. Zelek, Lorenzo Capitani, Charlotte Aimee Young, & B. Paul Morgan. (2021). Whole blood-based measurement of SARS-CoV-2-specific T cell responses reveals asymptomatic infection and vaccine efficacy in healthy subjects and patients with solid organ cancers. https://doi.org/10.1101/2021.06.02.21258218

Chicago

Thomas Tozer, Kate Davies, Lucy C. Fairclough, Martin J. Scurr, Michelle Somerville, Kerry Roberts, Andrew James Godkin, et al. 2021. “Whole Blood-Based Measurement of SARS-CoV-2-Specific T Cell Responses Reveals Asymptomatic Infection and Vaccine Efficacy in Healthy Subjects and Patients with Solid Organ Cancers,” June. doi:10.1101/2021.06.02.21258218.